We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

NeuroOne Medical Technologies Corp (NMTC) USD0.001

Sell:$0.78 Buy:$0.83 Change: $0.0125 (1.51%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
Change: $0.0125 (1.51%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
Change: $0.0125 (1.51%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

Contact details

7599 Anagram Dr
United States
+1 (952) 4261383

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$22.44 million
Shares in issue:
27.52 million
Health Care Equipment
United States
US dollar

Key personnel

  • David Rosa
    President, Chief Executive Officer, Director
  • Mark Christianson
    Co-Founder, Business Development Director - Medical Sales Liaison
  • Ronald Mcclurg
    Chief Financial Officer
  • Christopher Volker
    Chief Operating Officer
  • Steve Mertens
    Chief Technology Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.